CONDENSED CONSOLIDATED STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) - USD ($) $ in Thousands	Total	At The Market Offering [Member]	Series B Convertible Preferred Stock	Series A Convertible Preferred Stock [Member]	Series C Convertible Preferred Stock	Common Stock [Member]	Common Stock [Member] At The Market Offering [Member]	Subscription Receivable Preferred Stock Series A	Additional Paid In Capital	Additional Paid In Capital At The Market Offering [Member]	Additional Paid In Capital Series A Convertible Preferred Stock [Member]	Additional Paid In Capital Series C Convertible Preferred Stock	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Accumulated Deficit Series A Convertible Preferred Stock [Member]	Accumulated Deficit Series C Convertible Preferred Stock
Beginning balance at Dec. 31, 2023	$ (5,552)					$ 7			$ 161,252				$ 100	$ (166,911)
Beginning balance, shares at Dec. 31, 2023						3,548
Issuance of stock	10,082								10,082
Issuance of preferred stock Series upon conversion of debt, Shares				3,430,895
Issuance of preferred stock Series upon conversion of debt				$ 1
Subscription receivable for issuance of Series A preferred stock, shares				1,500,000
Subscription receivable for issuance of Series A preferred stock	(3,000)							$ (3,000)
Issuance of preferred stock series B upon acquisition of CLMBR, Inc, Shares			1,500,000
Issuance of preferred stock series B upon acquisition of CLMBR, Inc.			$ 2,688
Issuance of common stock upon acquisition of CLMBR, Inc, Shares						357
Issuance of common stock upon acquisition of CLMBR, Inc.	1,014					$ 0			1,014
Issuance of Common stock upon waiver to enter into Note Agreement						63
Issuance of Common stock upon waiver to enter into Note Agreement,Value	177					$ 0			177
Issuance of shares upon issuance of convertible notes, shares						188
Issuance of shares upon issuance of convertible notes	547					$ 0			547
Issuance of common stock from equity line of credit						328
Issuance of common stock from equity line of credit	692					$ 0			692
Issuance upon conversion of convertible notes, shares						371
Issuance of Common stock upon conversion of convertible notes	866					$ 0			866
Issuance of Common stock upon exercise of stock options, shares						4
Stock-based compensation	3,586								3,586
Foreign currency translation gain (loss)	39												39
Net Income (Loss)	(11,394)													(11,394)
Ending balance, shares at Mar. 31, 2024			1,500,000	4,930,895
Endng balance at Mar. 31, 2024			$ 2,688	$ 1
Ending balance at Mar. 31, 2024	(2,942)					$ 7		$ (3,000)	178,216				139	(178,305)
Ending balance, shares at Mar. 31, 2024						4,859
Beginning balance at Dec. 31, 2024	7,115					$ 8			209,509				183	(202,586)
Beginning balance at Dec. 31, 2024			$ 0	$ 1	$ 0
Beginning balance, shares at Dec. 31, 2024						1,402,102
Beginning balance, shares at Dec. 31, 2024			1,500,000	4,658,737	2,861,128
Issuance of stock		$ 1,594								$ 1,594
Issuance of stock, shares							821,500
Issuance of Common stock upon conversion of preferred stock			(1,060,118)	(100,000)	(2,801,250)
Issuance of Common stock upon conversion of Common Stock, shares						1,788,390
Issuance of preferred stock series C upon settlement of loss restoration agreement , shares					1,684,817
Issuance of preferred stock series C upon settlement of loss restoration agreement , value	3,128				$ 1				3,127
Series A Preferred dividends declared and paid in kind, shares				112,334	126,515
Series A Preferred dividends declared and paid in kind											$ 225	$ 253			$ (225)	$ (253)
Issuance upon conversion of convertible notes, shares						3,941,578
Issuance of Common stock upon conversion of convertible notes	5,799					$ 1			5,798
Gain on extinguishment of related party promissory notes	279													279
Stock-based compensation	2,423								2,423
Foreign currency translation gain (loss)	21												21
Net Income (Loss)	(6,603)													(6,603)
Ending balance, shares at Mar. 31, 2025			439,882	4,671,071	1,871,210
Endng balance at Mar. 31, 2025			$ 0	$ 1	$ 1
Ending balance at Mar. 31, 2025	$ 13,756					$ 9			$ 222,929				$ 204	$ (209,388)
Ending balance, shares at Mar. 31, 2025						7,953,570